0	8	NF-kappa	NF-kappa	NNP
9	10	B	B	NNP
11	19	controls	control	VBZ
20	30	expression	expression	NN
31	33	of	of	IN
34	43	inhibitor	inhibitor	NN
44	45	I	i	NN
46	51	kappa	kappa	NN
52	53	B	B	NNP
54	59	alpha	alpha	NN
59	60	:	:	:
61	69	evidence	evidence	NN
70	73	for	for	IN
74	76	an	an	DT
77	86	inducible	inducible	JJ
87	101	autoregulatory	autoregulatory	JJ
102	109	pathway	pathway	NN
109	110	.	.	.

112	115	The	the	DT
116	126	eukaryotic	eukaryotic	JJ
127	140	transcription	transcription	NN
141	147	factor	factor	NN
148	155	nuclear	nuclear	JJ
156	168	factor-kappa	factor-kappa	NN
169	170	B	B	NNP
171	172	(	(	(
172	180	NF-kappa	NF-kappa	NNP
181	182	B	B	NNP
182	183	)	)	)
184	196	participates	participate	VBZ
197	199	in	in	IN
200	204	many	many	JJ
205	210	parts	part	NNS
211	213	of	of	IN
214	217	the	the	DT
218	225	genetic	genetic	JJ
226	233	program	program	NN
234	243	mediating	mediate	VBG
244	245	T	t	NN
246	256	lymphocyte	lymphocyte	NN
257	267	activation	activation	NN
268	271	and	and	CC
272	278	growth	growth	NN
278	279	.	.	.

280	287	Nuclear	nuclear	JJ
288	298	expression	expression	NN
299	301	of	of	IN
302	310	NF-kappa	NF-kappa	NNP
311	312	B	B	NNP
313	319	occurs	occur	VBZ
320	325	after	after	IN
326	329	its	its	PRP$
330	337	induced	induce	VBN
338	350	dissociation	dissociation	NN
351	355	from	from	IN
356	359	its	its	PRP$
360	371	cytoplasmic	cytoplasmic	JJ
372	381	inhibitor	inhibitor	NN
382	383	I	i	NN
384	389	kappa	kappa	NN
390	391	B	B	NNP
392	397	alpha	alpha	NN
397	398	.	.	.

399	406	Phorbol	Phorbol	NNP
407	412	ester	ester	NN
413	416	and	and	CC
417	422	tumor	tumor	NN
423	431	necrosis	necrosis	NN
432	444	factor-alpha	factor-alpha	NN
445	454	induction	induction	NN
455	457	of	of	IN
458	465	nuclear	nuclear	JJ
466	474	NF-kappa	NF-kappa	NNP
475	476	B	B	NNP
477	479	is	be	VBZ
480	490	associated	associate	VBN
491	495	with	with	IN
496	500	both	both	CC
501	504	the	the	DT
505	516	degradation	degradation	NN
517	519	of	of	IN
520	529	performed	perform	VBN
530	531	I	i	NN
532	537	kappa	kappa	NN
538	539	B	B	NNP
540	545	alpha	alpha	NN
546	549	and	and	CC
550	553	the	the	DT
554	564	activation	activation	NN
565	567	of	of	IN
568	569	I	i	NN
570	575	kappa	kappa	NN
576	577	B	B	NNP
578	583	alpha	alpha	NN
584	588	gene	gene	NN
589	599	expression	expression	NN
599	600	.	.	.

601	613	Transfection	transfection	NN
614	621	studies	study	NNS
622	630	indicate	indicate	VBP
631	635	that	that	IN
636	639	the	the	DT
640	641	I	i	NN
642	647	kappa	kappa	NN
648	649	B	B	NNP
650	655	alpha	alpha	NN
656	660	gene	gene	NN
661	663	is	be	VBZ
664	676	specifically	specifically	RB
677	684	induced	induce	VBN
685	687	by	by	IN
688	691	the	the	DT
692	705	65-kilodalton	65-kilodalton	JJ
706	721	transactivating	transactivating	NN
722	729	subunit	subunit	NN
730	732	of	of	IN
733	741	NF-kappa	NF-kappa	NNP
742	744	B.	B.	NNP
745	756	Association	Association	NNP
757	759	of	of	IN
760	763	the	the	DT
764	769	newly	newly	RB
770	781	synthesized	synthesize	VBN
782	783	I	i	NN
784	789	kappa	kappa	NN
790	791	B	B	NNP
792	797	alpha	alpha	NN
798	802	with	with	IN
803	806	p65	p65	NN
807	815	restores	restore	VBZ
816	829	intracellular	intracellular	JJ
830	840	inhibition	inhibition	NN
841	843	of	of	IN
844	852	NF-kappa	NF-kappa	NNP
853	854	B	B	NNP
855	858	DNA	DNA	NNP
859	866	binding	binding	NN
867	875	activity	activity	NN
876	879	and	and	CC
880	888	prolongs	prolong	VBZ
889	892	the	the	DT
893	901	survival	survival	NN
902	904	of	of	IN
905	909	this	this	DT
910	916	labile	labile	JJ
917	926	inhibitor	inhibitor	NN
926	927	.	.	.

928	936	Together	together	RB
936	937	,	,	,
938	943	these	these	DT
944	951	results	result	NNS
952	956	show	show	VBP
957	961	that	that	IN
962	970	NF-kappa	NF-kappa	NNP
971	972	B	B	NNP
973	981	controls	control	VBZ
982	985	the	the	DT
986	996	expression	expression	NN
997	999	of	of	IN
1000	1001	I	i	NN
1002	1007	kappa	kappa	NN
1008	1009	B	B	NNP
1010	1015	alpha	alpha	NN
1016	1018	by	by	IN
1019	1024	means	mean	NNS
1025	1027	of	of	IN
1028	1030	an	an	DT
1031	1040	inducible	inducible	JJ
1041	1055	autoregulatory	autoregulatory	JJ
1056	1063	pathway	pathway	NN
1063	1064	.	.	.